Company Filing History:
1 out of 153 
1 out of 23 
1 out of 3,539 
Years Active: 2018
Title: The Innovations of Liangmin Huang
Introduction
Liangmin Huang is a notable inventor based in Xiamen, China. He has made significant contributions to the field of biotechnology, particularly in the development of solutions for respiratory syncytial virus (RSV) infections. His work has implications for vaccine development and therapeutic interventions.
Latest Patents
Liangmin Huang holds a patent for an invention titled "Epitope of RSV fusion protein and antibody recognizing the same." This invention relates to an epitope peptide that can be utilized in preventing RSV infection. It includes a recombinant protein comprising the epitope peptide and a carrier protein, along with various uses of the epitope peptide and the recombinant protein. Additionally, the patent covers an antibody against the epitope peptide, a cell line for generating the antibody, and potential applications for a vaccine or pharmaceutical composition aimed at preventing symptoms associated with RSV infection. He has 1 patent to his name.
Career Highlights
Liangmin Huang has worked at Xiamen University and Xiamen Innovax Biotech Co., Ltd. His roles in these institutions have allowed him to collaborate with other experts in the field and contribute to important research initiatives.
Collaborations
Some of his notable coworkers include Zizheng Zheng and Jason Scott McLellan. Their collaborative efforts have likely enhanced the research and development processes in which they have been involved.
Conclusion
Liangmin Huang's innovative work in the field of biotechnology, particularly regarding RSV, showcases his commitment to advancing medical science. His contributions are vital for developing effective treatments and preventive measures against viral infections.